PEAK6
MRNA icon

PEAK6’s Moderna MRNA Stock Holding History

PEAK6’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15.3M Sell
301,700
-241,800
-44% -$11.3M 0.04% 436
2025
Q4 		$16M Buy
543,500
+24,500
+5% +$666K 0.03% 447
2025
Q3 		$13.4M Sell
519,000
-327,400
-39% -$9.13M 0.02% 561
2025
Q2 		$23.4M Buy
846,400
+179,400
+27% +$4.72M 0.04% 347
2025
Q1 		$18.9M Buy
667,000
+276,600
+71% +$9.82M 0.04% 355
2024
Q4 		$16.2M Buy
+390,400
New +$18.7M 0.03% 389

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PEAK6's MRNA Position: Q1 2026 in Review

PEAK6 reduced its Moderna (MRNA) stake by 37% in Q1 2026, selling an estimated $1.67M and leaving 60,583 shares worth $3.08M. The position accounts for 0.01% of the portfolio, ranked #1148.

PEAK6 first reported a position in MRNA in Q4 2024 and has held it in 6 quarters since. The position peaked at $8.67M in Q2 2025. 722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • PEAK6 held 60,583 shares of Moderna worth $3.08M as of Q1 2026.
  • PEAK6 sold 35,773 Moderna shares in Q1 2026, an estimated $1.67M.
  • Moderna made up 0.01% of PEAK6's portfolio in Q1 2026, its #1148 holding.
  • PEAK6 first reported a position in Moderna in Q4 2024 and has held it in 6 quarters since.
  • PEAK6's Moderna position peaked at $8.67M in Q2 2025.
  • 722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on PEAK6's 13F filing for Q1 2026, filed 14 May 2026.